摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4H-thieno[3,2-b]pyrrol-6-yl)-ethylamine | 36004-21-4

中文名称
——
中文别名
——
英文名称
2-(4H-thieno[3,2-b]pyrrol-6-yl)-ethylamine
英文别名
6-(2-Aminoethyl)thieno<3,2-b>pyrrol;2-(4H-thieno[3,2-b]pyrrol-6-yl)ethanamine
2-(4<i>H</i>-thieno[3,2-<i>b</i>]pyrrol-6-yl)-ethylamine化学式
CAS
36004-21-4
化学式
C8H10N2S
mdl
——
分子量
166.247
InChiKey
XLMGTYWPFUGNSS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    347.9±27.0 °C(Predicted)
  • 密度:
    1.300±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    70
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    6-piperidin-1-ylmethyl-4H-thieno[3,2-b]pyrrole 在 lithium aluminium tetrahydride 作用下, 以 乙醚 为溶剂, 生成 2-(4H-thieno[3,2-b]pyrrol-6-yl)-ethylamine
    参考文献:
    名称:
    6-取代的噻吩并(3,2-b)吡咯的合成。色氨酸,色胺和吲哚乙酸的类似物。
    摘要:
    DOI:
    10.1021/jo00796a014
点击查看最新优质反应信息

文献信息

  • N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands
    申请人:Cole Cecil Derek
    公开号:US20060160878A1
    公开(公告)日:2006-07-20
    The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a CNS disorder relating to or affected by the 5-HT6 receptor.
    本发明提供了公式I的化合物以及其在治疗与或受5-HT6受体相关的中枢神经系统疾病方面的用途。
  • N-SULFONYLHETEROCYCLOPYRROLYLALKYLAMINE COMPOUNDS AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
    申请人:Wyeth
    公开号:EP1648904B1
    公开(公告)日:2007-08-22
  • TREATING SOLUTION FOR ELECTRONIC PARTS, AND PROCESS FOR PRODUCING ELECTRONIC PARTS
    申请人:FINE POLYMERS CORPORATION
    公开号:US20150279654A1
    公开(公告)日:2015-10-01
    The invention provides an aqueous solution capable of selectively protecting a nitrogen-containing silicon compound from corrosion by a treating solution for etching, cleaning or the like, etching oxygen-containing, carbon-containing silicon in particular, and making a large etch rate difference between a nitrogen-containing silicon compound and an oxygen-containing silicon compound, and a process for producing electronic parts as well. The invention is embodied by a treating solution for electronic parts that is an aqueous solution containing one or two or more of anionic surface active agents represented by the following formulae (1), (2) and (3), and a process for producing an electronic part. wherein R 1 , R 2 , and R 3 stands for hydrogen or an alkyl or alkylene group having 1 to 4 carbon atoms, and X 1 stands for a functional group capable of becoming an anionic ion. wherein R 4 stands for hydrogen or an alkyl or alkylene group having 1 to 4 carbon atoms, X 2 stands for a functional group capable of becoming an anionic ion, and n stands for a natural number of greater than 2. wherein R 5 stands for hydrogen or an alkyl or alkylene group having 1 to 4 carbon atoms, and X 3 , and X 4 stands for a functional group capable of becoming an anionic ion.
  • US7041695B2
    申请人:——
    公开号:US7041695B2
    公开(公告)日:2006-05-09
  • US7220756B2
    申请人:——
    公开号:US7220756B2
    公开(公告)日:2007-05-22
查看更多

同类化合物

N-甲基-n-[(4-甲基-4H-噻吩并[3,2-b]吡咯-5-基)甲基]胺盐酸盐 6H-噻吩并[2,3-b]吡咯-5-羧酸甲酯 6H-噻吩并[2,3-b]吡咯-5-羧酸乙酯 6H-噻吩并[2,3-b]吡咯-5-羧酸 6-[(3-氨基苯基)甲基]-4,6-二氢-4-甲基-2-(甲基亚磺酰)-5H-噻吩并[2',3':4,5]吡咯并[2,3-D]哒嗪-5-酮 4H-噻唑[3,2-B]吡咯-5-甲酸 4H-噻吩并[3,2-b]吡咯-5-羧酸甲酯 4H-噻吩并[3,2-B]吡咯-5-甲酰肼 4H-噻吩并[3,2-B]吡咯-5-甲酰氯 4H-噻吩并[3,2-B]吡咯-2-羧酸 4H-噻吩[3,2-b]吡咯-5-羧酸乙酯 4H-Dithieno[3,2-b:2',3'-d]吡咯,4-(1-辛基壬基)- 4-辛基-4H-二噻吩并[3,2-b:2,3-d]吡咯 4-甲基-4H-噻吩并[3,2-b]吡咯-5-羧酸甲酯 4-甲基-4H-噻吩并[3,2-b]吡咯-5-羧酸乙酯 4-甲基-4H-噻吩并[3,2-b]吡咯-5-羧酸 4-甲基-4H-噻[3,2-B]吡咯-5-甲醛 4-R-4H-二噻吩并[3,2-b:2',3'-d]吡咯 3-甲基-4H-噻吩并[3,2-B]吡咯-5-羧酸乙酯 3-溴-4H-噻吩并[3,2-b]吡咯-5-羧酸乙酯 3-溴-4H-噻吩并[3,2-b]吡咯-5-羧酸 3-溴-4H-噻吩并[3,2-B]吡咯-5-羧酸甲酯 3-氯-4H-噻吩并[3,2-b]吡咯-5-羧酸 2-甲酰基-4H-噻吩并[3,2-B]吡咯-5-羧酸乙酯 2-甲基-4H-噻吩并[3,2-b]吡咯-5-羧酸乙酯 2-甲基-4H-噻吩并[3,2-b]吡咯-5-羧酸 2-溴-6-甲酰基-4H-噻吩并[3,2-b]吡咯-5-羧酸乙酯 2-溴-6-甲酰基-4-甲基-4H-噻吩并[3,2-B]吡咯-5-羧酸乙酯 2-溴-4H-噻吩并[3,2-b]吡咯-5-羧酸乙酯 2-溴-4,6-二氢-4-甲基-5H-噻吩并[2,3:4,5]吡咯并[2,3-d]吡嗪-5-酮 2-氯-6H-噻吩并[2,3-b]吡咯-5-羧酸乙酯 2-氯-6H-噻吩并[2,3-B]吡咯-5-羧酸甲酯 2-氯-4H-噻吩并[3,2-b]吡咯-5-羧酸甲酯 2-氯-4H-噻吩并[3,2-b]吡咯-5-羧酸乙酯 2-氯-4H-噻吩并[3,2-b]吡咯-5-羧酸 2-氯-3-甲基-4H-噻吩并[3,2-B]吡咯-5-羧酸乙酯 2,6-二溴-4-正辛基二噻吩并[3,2-b:2',3'-d]吡咯 2,6-二溴-4-(2-乙基己基)-4H-二噻吩并[3,2-b:2,3-d]吡咯 2,3-二氯-4H-噻吩并[3,2-b]吡咯-5-羧酸 (4-甲基-4H-噻吩并[3,2-b]吡咯-5-基)甲醇 (4-(叔丁氧基羰基)-2-氯-4H-噻吩并[3,2-B]吡咯-5-基)硼酸 3-bromo-2-methyl-4H-thieno[3,2-b]pyrrole-5-carboxylic acid methyl ester 5-thiophen-3-yl-thieno[3,2-b]pyrrole-4-carboxylic acid tert-butyl ester tert-butyl 5-butyl-4H-thieno[3,2-b]pyrrole-4-carboxylate tert-butyl 4H-thieno[3,2-b]pyrrole-4-carboxylate 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbohydrazide (4-methyl-piperazin-1-yl)-(3-methyl-4H-thieno[3,2-b]pyrrol-5-yl)-methanone 5-methyl-4H-thieno[3,2-b]pyrrole 4-hexyl-2,6-bis(thiophen-2-ylethynyl)-4H-dithieno[3,2-b;2′,3′-d]pyrrole 4-(3-chlorobenzyl)-2,6-bis-phenylethynylthieno[3,2-b]pyrrole-5-carboxylic acid (2-methoxyethyl)amide